InvestorsHub Logo

NSX

Followers 164
Posts 8408
Boards Moderated 0
Alias Born 01/31/2018

NSX

Re: None

Sunday, 10/14/2018 11:30:30 AM

Sunday, October 14, 2018 11:30:30 AM

Post# of 111071
DD on Caverstem then StemSpine:

I expect revenue generation for Caverstem to begin materializing Q3 and Q4, then it should begin to increase Q1-Q3 of 2019.

I then fully expect the release and start of commercialization of StemSpine next-perhaps early 2020 during an AAOS (American Academy of Orthopedic Surgeons which tends to meet in March of each calendar year

OR

October 2020, during the An American Academy of Spine Surgeons meeting based on my own DD by looking at this website:

https://theconferencewebsite.com/conferences/spine-surgery

My research and my opinion. My opinions is not a recommendation to buy or sell a security. Your decision whether or not to make a purchase should be based on your own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News